Literature DB >> 31906785

Global Burden of Head and Neck Cancer: Economic Consequences, Health, and the Role of Surgery.

Rolvix H Patterson1,2, Victoria G Fischman2, Isaac Wasserman1,3, Jennifer Siu4,5, Mark G Shrime1,6, Johannes J Fagan7, Wayne Koch8, Blake C Alkire1,6.   

Abstract

OBJECTIVE: We aimed to describe the mortality burden and macroeconomic effects of head and neck cancer as well as delineate the role of surgical workforce in improving head and neck cancer outcomes. STUDY
DESIGN: Statistical and economic analysis.
SETTING: Research group. SUBJECTS AND METHODS: We conducted a statistical analysis on data from the World Development Indicators and the 2016 Global Burden of Disease study to describe the relationship between surgical workforce and global head and neck cancer mortality-to-incidence ratios. A value of lost output model was used to project the global macroeconomic effects of head and neck cancer.
RESULTS: Significant differences in mortality-to-incidence ratios existed between Global Burden of Disease study superregions. An increase of surgical, anesthetic, and obstetric provider density by 10% significantly correlated with a reduction of 0.76% in mortality-to-incidence ratio (P < .0001; adjusted R2 = 0.84). There will be a projected global cumulative loss of $535 billion US dollars (USD) in economic output due to head and neck cancer between 2018 and 2030. Southeast Asia, East Asia, and Oceania will suffer the greatest gross domestic product (GDP) losses at $180 billion USD, and South Asia will lose $133 billion USD.
CONCLUSION: The mortality burden of head and neck cancer is increasing and disproportionately affects those in low- and middle-income countries and regions with limited surgical workforces. This imbalance results in large and growing economic losses in countries that already face significant resource constraints. Urgent investment in the surgical workforce is necessary to ensure access to timely surgical services and reverse these negative trends.

Entities:  

Keywords:  cancer; global health; global surgery; head and neck cancer; macroeconomics; otolaryngology; surgery; workforce

Mesh:

Year:  2020        PMID: 31906785     DOI: 10.1177/0194599819897265

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  17 in total

1.  Making the Best of Limited Resources: Improving Outcomes in Head and Neck Cancer.

Authors:  Johannes J Fagan; Vanita Noronha; Evan Michael Graboyes
Journal:  Am Soc Clin Oncol Educ Book       Date:  2021-03

2.  TP53 mutation-associated immune infiltration and a novel risk score model in HNSCC.

Authors:  Weili Kong; Yinze Han; Hailing Gu; Hui Yang; Yi Zang
Journal:  Biochem Biophys Rep       Date:  2022-10-13

3.  Clinicopathology and Treatment Patterns of Head and Neck Cancers in Ethiopia.

Authors:  Adugna Fekadu; Tara J Rick; Wondemagegnhu Tigeneh; Eva Johanna Kantelhardt; Luca Incrocci; Ahmedin Jemal
Journal:  JCO Glob Oncol       Date:  2022-08

4.  Systemic Immun e-Inflammation Index as a Predictor for Head and Neck Cancer Prognosis: A Meta-Analysis.

Authors:  Yun-Ting Wang; Liang-Tseng Kuo; Hsu-Huei Weng; Cheng-Ming Hsu; Ming-Shao Tsai; Geng-He Chang; Yi-Chan Lee; Ethan I Huang; Yao-Te Tsai
Journal:  Front Oncol       Date:  2022-06-24       Impact factor: 5.738

Review 5.  Therapeutic approaches for the treatment of head and neck squamous cell carcinoma-An update on clinical trials.

Authors:  Bharat Goel; Anoop Kumar Tiwari; Rajeev Kumar Pandey; Akhand Pratap Singh; Sujeet Kumar; Abhishek Sinha; Shreyans K Jain; Arun Khattri
Journal:  Transl Oncol       Date:  2022-04-20       Impact factor: 4.803

6.  Cancer Prevention in Low-Resource Countries: An Overview of the Opportunity.

Authors:  Sailaja Kamaraju; Jeffrey Drope; Rengaswamy Sankaranarayanan; Surendra Shastri
Journal:  Am Soc Clin Oncol Educ Book       Date:  2020-03

Review 7.  Biological roles and clinical significance of estrogen and androgen receptors in head and neck cancers.

Authors:  Chunhong Qin; Yan Lu; Huimin Zhang; Zhe Zhang; Wei Xu; Shuxin Wen; Wei Gao; Yongyan Wu
Journal:  J Cancer       Date:  2022-04-04       Impact factor: 4.478

8.  Ex Vivo Expanded Circulating Tumor Cells for Clinical Anti-Cancer Drug Prediction in Patients with Head and Neck Cancer.

Authors:  Kuan-Chou Lin; Lai-Lei Ting; Chia-Lun Chang; Long-Sheng Lu; Hsin-Lun Lee; Fang-Chi Hsu; Jeng-Fong Chiou; Peng-Yuan Wang; Thierry Burnouf; Dennis Chun-Yu Ho; Kai-Chiang Yang; Chang-Yu Chen; Chu-Huang Chen; Ching-Zong Wu; Yin-Ju Chen
Journal:  Cancers (Basel)       Date:  2021-12-02       Impact factor: 6.639

Review 9.  Global head and neck surgery research during the COVID pandemic: A bibliometric analysis.

Authors:  Olga Mbougo Djoutsop; Jolyvette Voufo Mbougo; Ulrick Sidney Kanmounye
Journal:  Ann Med Surg (Lond)       Date:  2021-07-09

10.  Africa: A window on challenges and opportunities for head and neck cancer.

Authors:  Johannes J Fagan
Journal:  Laryngoscope Investig Otolaryngol       Date:  2021-03-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.